Back to AZN overview

AZN Astrazeneca PE ratio, current and historical analysis

The current PE ratio for Astrazeneca stock as of Jun 20, 2024 is 38.32. This is calculated based on the TTM EPS of $2.05 and the stock price of $78.56 per share. The PE ratio marks an increase of 10% from its last 4 quarters average of 34.9.

AZN PE ratio history

How has AZN's PE ratio performed in the past

The average historical PE ratio of Astrazeneca for the last ten years is 85.02. The current P/E ratio of 38.32 is 55% lower than the historical average. Looking back at the last ten years, AZN's PE ratio peaked in the Dec 2021 quarter at 1,456.25, when the price was $58.25 and the EPS was $0.04. The lowest point was in the Dec 2016 quarter, when it reached 19.65 with a price of $27.32 and an EPS of $1.39.

Average
85.02
Median
42.08
Minimum
19.65
Maximum
1,456.25

Astrazeneca PE ratio by year

Maximum annual increase: 3,453.56% in 2021

Maximum annual decrease: -95.61% in 2022

Year PE ratio Change
2023 35.08 -45.15%
2022 63.96 -95.61%
2021 1,456.25 3,453.56%
2020 40.98 -57.26%
2019 95.88 114.59%
2018 44.68 53.22%
2017 29.16 48.4%
2016 19.65 -35.17%
2015 30.31 -57.8%
2014 71.82 146.8%

AZN average PE ratio chart

What is the average PE ratio of AZN for the past years

Currently, AZN's PE ratio is lower than its 3, 5 and 10-year averages.

3-year avg
193.74
5-year avg
133.84
10-year avg
85.02
15-year avg
59.65

AZN PE vs peers

What is AZN's PE ratio compared to its peers

In comparison to its peers LLY and MRK, AZN's PE ratio is lower, but it is higher than JNJ's and NVS's. Astrazeneca's PE ratio is trading above the peer average of 21.24.

Stock name PE ratio Market cap
JNJ Johnson & Johnson 9.75 $357.99B
NVS Novartis AG 14.2 $214.69B
BIIB Biogen Inc 27.85 $32.64B
ABT Abbott Laboratories 32.73 $183.91B
AZN Astrazeneca plc 38.48 $244.55B
LLY ELI LILLY & Co 129.6 $840.04B
MRK Merck & Co Inc 143.65 $331.09B
PFE Pfizer Inc N/A $157.19B
BMY Bristol Myers Squibb Co N/A $85B

Frequently asked questions

What is Astrazeneca's PE ratio?

AZN stock has a price to earnings ratio of 38.32 as of Jun 20, 2024.

What is the 3-year average PE ratio for Astrazeneca (AZN)?

The 3-year average price to earnings ratio for AZN stock is 193.74.

What is the 5-year average PE ratio for Astrazeneca (AZN)?

The 5-year average price to earnings ratio for AZN stock is 133.84.

What is the highest PE ratio for AZN?

Over the last ten years, the quarterly PE ratio reached its highest level at 1,456.25 in the Dec 2021 quarter.

How does the current PE ratio for AZN compare to its historical average?

The current PE ratio of AZN is 55% lower than the 10-year historical average.

How is AZN's PE ratio calculated (Astrazeneca PE ratio formula)?

You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 20, 2024), Astrazeneca's share price is $78.56. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.05. Therefore, Astrazeneca's PE ratio for today is 38.32. PE RATIO(38.32) = STOCK PRICE($78.56) / TTM EPS($2.05)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.